Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis.

Autor: Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, Wilschut JA, Zauber AG, van Ballegooijen M, Lansdorp-Vogelaar, Iris, Kuntz, Karen M, Knudsen, Amy B, Wilschut, Janneke A, Zauber, Ann G, van Ballegooijen, Marjolein

Publikováno v: Annals of Internal Medicine; 9/21/2010, Vol. 153 Issue 6, p368-377, 10p

Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.

Autor: Mfumbilwa ZA; Department of Epidemiology and Data Science, Disease Modelling and Health Care Evaluation, Amsterdam UMC, Location Vrije Universiteit Amsterdam, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.; Amsterdam Public Health, Methodology, Amsterdam, The Netherlands.; Department of Mathematics and Statistics, Sokoine University of Agriculture, Morogoro, Tanzania., Simons MJHG; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Ramaekers B; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Retèl VP; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Mankor JM; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands., Groen HJM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Aerts JGJV; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands., Joore M; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Wilschut JA; Department of Epidemiology and Data Science, Disease Modelling and Health Care Evaluation, Amsterdam UMC, Location Vrije Universiteit Amsterdam, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.; Amsterdam Public Health, Methodology, Amsterdam, The Netherlands., Coupé VMH; Department of Epidemiology and Data Science, Disease Modelling and Health Care Evaluation, Amsterdam UMC, Location Vrije Universiteit Amsterdam, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. v.coupe@amsterdamumc.nl.; Amsterdam Public Health, Methodology, Amsterdam, The Netherlands. v.coupe@amsterdamumc.nl.

Publikováno v: PharmacoEconomics [Pharmacoeconomics] 2024 Apr; Vol. 42 (4), pp. 419-434. Date of Electronic Publication: 2024 Jan 09.

Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands.

Autor: Mfumbilwa ZA; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, PO Box 7057, 1007 MB, Amsterdam, The Netherlands., Wilschut JA; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, PO Box 7057, 1007 MB, Amsterdam, The Netherlands., Simons MJHG; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Maastricht University, Care And Public Health Research Institute (CAPHRI), Maastricht, The Netherlands., Ramaekers B; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Maastricht University, Care And Public Health Research Institute (CAPHRI), Maastricht, The Netherlands., Joore M; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Maastricht University, Care And Public Health Research Institute (CAPHRI), Maastricht, The Netherlands., Retèl V; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., der Welle CMC; Santeon Hospital Group, Santeon, Herculesplein 38, 3584 AA, Utrecht, The Netherlands., Schramel FMNH; Santeon Hospital Group, Santeon, Herculesplein 38, 3584 AA, Utrecht, The Netherlands., van de Garde EMW; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, The Netherlands., Coupé VMH; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. v.coupe@amsterdamumc.nl.

Publikováno v: Scientific reports [Sci Rep] 2023 Feb 09; Vol. 13 (1), pp. 2349. Date of Electronic Publication: 2023 Feb 09.

Administrative healthcare data as an addition to the Dutch surgical aneurysm audit to evaluate mid-term reinterventions following abdominal aortic aneurysm repair: A pilot study.

Autor: Alberga AJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands; Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: a.alberga@erasmusmc.nl., Stangenberger VA; LOGEX b.v, Amsterdam, The Netherlands., de Bruin JL; Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands., Wever JJ; Department of Vascular Surgery, Haga Teaching Hospital, The Hague, The Netherlands., Wilschut JA; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands., van den Brand CL; Emergency Department, Erasmus University Medical Center, Rotterdam, The Netherlands., Verhagen HJM; Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands., W J M Wouters M; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: International journal of medical informatics [Int J Med Inform] 2022 Aug; Vol. 164, pp. 104806. Date of Electronic Publication: 2022 May 31.

Case-mix adjustment to compare colonoscopy performance between endoscopy centers: a nationwide registry study.

Autor: Nass KJ; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Dutch Institute for Clinical Auditing, Leiden, The Netherlands., van der Vlugt M; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Elfrink AKE; Dutch Institute for Clinical Auditing, Leiden, The Netherlands., van den Brand CL; Dutch Institute for Clinical Auditing, Leiden, The Netherlands., Wilschut JA; Dutch Institute for Clinical Auditing, Leiden, The Netherlands., Fockens P; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Dekker E; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Endoscopy [Endoscopy] 2022 May; Vol. 54 (5), pp. 455-462. Date of Electronic Publication: 2021 Oct 28.